10-Formyl-5,8,10-trideazafolic acid (10-formyl-TDAF): a potent inhibitor of glycinamide ribonucleotide transformylase.

D L Boger, N E Haynes, P A Kitos, M S Warren, J Ramcharan, A E Marolewski, S J Benkovic

Department of Chemistry, Scripps Research Institute, La Jolla, CA 92037, USA.

Bioorganic & medicinal chemistry 1997 Sep

filter terms:

The synthesis of 10-formyl-5,8,10-trideazafolic acid (3) as a potential inhibitor of glycinamide ribonucleotide transformylase (GAR Tfase) is reported. The target compound was prepared by a convergent synthesis utilizing the alkylation of hydrazone 5 with benzylic bromide 6 to construct the core heterocycle 7. The aldehyde 3 and related agents were evaluated as inhibitors of purN GAR Tfase and avian AICAR Tfase. Compound 3 exhibited potent inhibition of GAR Tfase with a Ki of 0.26 +/- 0.05 microM. In contrast, 3 exhibited more moderate inhibition of aminoimidazole carboxamide ribonucleotide transformylase (AICAR Tfase), with Ki of 7.6 +/- 1.5 microM.

Citation

D L Boger, N E Haynes, P A Kitos, M S Warren, J Ramcharan, A E Marolewski, S J Benkovic. 10-Formyl-5,8,10-trideazafolic acid (10-formyl-TDAF): a potent inhibitor of glycinamide ribonucleotide transformylase. Bioorganic & medicinal chemistry. 1997 Sep;5(9):1817-30